Economy
Financial Markets
Commodities
Industries
Energy
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks


 
Company - Domestic
 Search News  Or
Nanjing Pharma to raise RMB 1.06 bln via private placement

Sep. 18, 2012 (China Knowledge) - Nanjing Pharmaceutical Co Ltd<600713>, principally engaged in manufacturing and distribution of Chinese medicines and western drugs, has announced plans to raise  RMB 1.06 billion via a private placement.

The company said it will issue 204 million A-shares at a price of RMB 5.2 to two companies, comprising its parent company, Nanjing Pharmaceutical Group Co, and Alliance Boots, a world famous pharmaceutical retailer and wholesaler.

Nanjing Pharmaceutical Group will subscribe 96.15 million shares or 47.17% with RMB 500 million, while Alliance Boots will subscribe 108 million shares with RMB 560 million.

After the deal, Nanjing Pharmaceutical Group will hold 26.94% stake in Nanjing Pharmaceutical Co, while Alliance Boots will hold a 12% stake in the company and become its second largest shareholder.

RMB 800 million of the proceeds from the issue will be used to repay bank loans, while the rest proceeds will be used to replenish working capital, said Nanjing Pharmaceutical Co.







Add this     
Copyright © "2015" www.chinaknowledge.com

Send feedback or comments to: news@chinaknowledge.com

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services

 E-Store

 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved